Workshop to support Civil Society and Stake Holders in the MENA region

1              2          3

The Global Fund to fight AIDS, Tuberculosis and Malaria, the Stop TB Partnership, and the Middle East and North Africa Harm Reduction Association (MENAHRA) are pleased to organize workshop to support countries in the Middle East and North Africa that are submitting HIV, TB and Malaria Global Fund Concept Notes in 2015. The workshop is co-sponsored by the Stop TB Partnership and facilitated by MENAHRA, and will take place from the 16th to the 18th of December 2014, in Gefinor Rotana Hotel, Beirut, Lebanon.

Read more...

Unodc-Menahra Regional Conference on OST & NSP

UNODC-MENAHRA REGIONAL CONFERENCE on Opioid Substitution Therapy– Needle and Syringe Programme  11-13 November 2014, Casablanca, Morocco

10388200 10152763183585081 5269111720952072487 n

MENAHRA and UNODC organized a joint Regional Conference on Opioid Substitution Therapy (OST) - Needle and Syringe Programme (NSP). The Conference took place in Casablanca, Morocco from 11-13 November 2014.

Read more...

Operational Research on refugees and injecting drug use

Due to an increase in refugee populations within MENA countries, a number of public health issues and concerns have arose due to the living conditions of the refugees in the region. Hence, MENAHRA started a research to conduct an operational research on refugees and injecting drug use in the region. This research will target the following five countries from its three sub-regions: Egypt, Iran, Jordan, Lebanon, and Tunisia. It will be coordinated by the MENAHRA Network Secretariat with support from the three Knowledge Hubs and other partners. Country focal points will be identified to coordinate country work with major stakeholders, including National AIDS Control Programs (NAP). The results from this research will be used as an evidence-based advocacy tool for promoting targeted harm reduction programs for refugees across the region.

 

Success Story-Drug Users & Methadone Maintenance Therapy outcome

1

Kabul, the capital of Afghanistan, consists of 7 million populations from original Kabuli and from different provinces and returnees from neighbor’s countries. Kabul is known as heroin transient smuggling way, consist of more than 1000,000 people countrywide who use drug and more than 20,000 injecting drug users, there is increment of drug users. While Mĕdecines Du Monde Started a comprehensive and module Harm Reduction Program in Kabul Afghanistan (2006), for many years detoxification was the only intervention available, some authorities were opposite for the Harm Reduction Program even, much still to MMT. As detoxification has 90% relapsed (WHO), MDM has been persisted on comprehensive Harm Reduction Program, that’s why MDM attempted to start a Pilot MMT program in Afghanistan-Kabul for people who use drug particularly for injectors to reduce Blood Born Diseases (HIV/AIDs and HCV) prevalence among them. Finally after much more attempts and struggling against Ministry of Counter Narcotic and DRC, MDM enabled to start Methadone Maintenance Therapy Practically in Kabul February 2010.

Read more...

Populations Size Estimation and Mapping for IDUs and MSM Workshop

IMG-20140822-WA004

The Middle East and North Africa Harm Reduction Association (MENAHRA), in collaboration with the National AIDS Program (NAP) in Lebanon, is implementing a Populations Size Estimation and Bio-Behavioral Survey Mapping for Injecting Drug Users (IDUs) and Men who have Sex with Men (MSM) in Lebanon. This study was developed in order to contribute to addressing the lack of data and the need for more accurate information related to the IDU and MSM populations, which is resulting in the inability to deploy evidence-based planning and proper prioritization of services needed and geographical distribution of services.

Read more...

SUBSCRIBE TO OUR NEWSLETTER